Format:
14
,
Illustrationen
ISSN:
1573-7373
Content:
Isocitrate dehydrogenase 1 (IDH1) mutations are associated with improved survival in gliomas. Depending on the IDH1 status, TERT promoter mutations affect prognosis. IDH1 mutations are associated with alpha-thalassemia/mental retardation syndrome X-linked (ATRX) mutations and alternative lengthening of telomeres (ALT), suggesting an interaction between IDH1 and telomeres. However, little is known how IDH1 mutations affect telomere maintenance.
Note:
Gesehen am 14.04.2020
In:
Journal of neuro-oncology, Dordrecht [u.a.] : Springer Science + Business Media B.V, 1983, 147(2020), 1, Seite 1-14, 1573-7373
In:
volume:147
In:
year:2020
In:
number:1
In:
pages:1-14
In:
extent:14
Language:
English
DOI:
10.1007/s11060-020-03394-y
URL:
Volltext
(lizenzpflichtig)